即刻乳房再造与乳腺癌相关淋巴水肿发生风险的关联
2006至2016年回顾性队列纳入5900例因原发性乳腺癌行乳房切除术的患者,最终分析5497例。即刻乳房再造组5年淋巴水肿累积发生率9.6%,未再造对照组为12.2%(P=0.02);多因素分析中即刻乳房再造是淋巴水肿的独立预测因素(HR 0.75,95%CI 0.56–0.99,P=0.042)。
要点
- 即刻乳房再造与淋巴水肿风险降低相关(HR 0.75,95%CI 0.56–0.99,P=0.042)。
- 5年淋巴水肿累积发生率:即刻再造组9.6% vs 未再造对照组12.2%(P=0.02)。
- BMI<30 kg/m2、清扫淋巴结<10枚或接受辅助放疗的亚组中关联仍显著。
核心结论
- 即刻乳房再造与淋巴水肿风险降低相关,结果可能用于预测乳房再造后淋巴水肿的发生。
研究设计与样本
- 2006至2016年开展的回顾性队列研究,纳入5900例因原发性乳腺癌行乳房切除术并接受或不接受即刻乳房再造的连续患者。
主要发现
- 最终分析5497例(平均年龄51.7岁),其中630例发生淋巴水肿。
- 即刻乳房再造组5年淋巴水肿累积发生率为9.6%,未再造对照组为12.2%(P=0.02)。
- 多因素分析中即刻乳房再造状态是淋巴水肿的独立预测因素(HR 0.75,95%CI 0.56–0.99,P=0.042)。
- 亚组分析中,BMI<30 kg/m2者(P=0.024)、清扫淋巴结<10枚者(P=0.042)及接受辅助放疗者(P=0.048)的关联仍显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the increasing number of patients undergoing immediate breast reconstruction after mastectomy, the impact of immediate breast reconstruction on the risk of breast cancer-related lymphedema has become an emerging area of interest. This study aimed to identify the association between immediate breast reconstruction and postoperative lymphedema. METHODS: A retrospective cohort study was conducted from 2006 to 2016 with 5900 consecutive patients who underwent mastectomy for primary breast cancer with or without immediate breast reconstruction. After excluding patients with synchronous contralateral breast cancer, lymphedema before mastectomy, history of procedures performed in the axillary region, and follow-up data of less than 1 year, the cumulative incidence of lymphedema after immediate breast reconstruction and after no reconstruction was calculated and compared using multivariate Cox regression analysis. RESULTS: Overall, 5497 patients (mean age, 51.7 years) were included, and 630 developed lymphedema. The 5-year cumulative incidence rate of lymphedema was significantly reduced in patients who underwent immediate breast reconstruction versus control patients (9.6% versus 12.2%; P = 0.02). In the multivariate analysis, immediate breast reconstruction status (hazard ratio, 0.75; 95% confidence interval, 0.56 to 0.99; P = 0.042) was an independent predictor for lymphedema. Similar significant associations were observed in the subgroup analyses of patients with a body mass index less than 30 kg/m2 (P = 0.024), in those with fewer than 10 dissected lymph nodes (P = 0.042), or in those with adjuvant radiotherapy (P = 0.048). CONCLUSIONS: Immediate breast reconstruction was associated with a reduced risk of lymphedema. These results may be used for predicting the development of lymphedema following breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.
引用
- Jeon HB, Jung JH, Im SH, et al. Association between Immediate Breast Reconstruction and the Development of Breast Cancer-Related Lymphedema. Plast Reconstr Surg. 2022. PMID: 36696309. doi:10.1097/PRS.0000000000009831
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。